This biotechnology platform cultivates and optimizes cooperative microbial communities for specific applications. It identifies synergistic relationships between intestinal microorganism strains to create functional combinations, enabling the development of targeted microbial solutions.
Funding
$1.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Developing targeted microbial solutions is challenging due to the complexity of identifying synergistic relationships between different microorganism strains. Optimizing cooperative microbial communities for specific applications requires extensive research and data analysis to determine the most effective combinations.
Solution
Biomeates utilizes a microbiome big data platform to identify optimal microbial strain combinations that exhibit synergistic effects. The platform cultivates and optimizes these cooperative microbial communities for specific applications, enabling the creation of targeted microbial solutions. By analyzing vast amounts of microbiome data, Biomeates identifies "Mates"—optimal strain combinations that produce superior results. This approach facilitates the development of effective and targeted microbial products.
Target Audience
The primary customers are biotechnology companies and research institutions seeking to develop targeted microbial solutions for various applications.
Features
- Microbiome big data analysis for identifying synergistic microbial strain relationships.
- Cultivation and optimization of cooperative microbial communities.
- Identification of "Mates"—optimal strain combinations for specific applications.
- Development of targeted microbial solutions based on data-driven insights.